Patients with serious chronic rhinitis should be treated with combination drugs, according to new guidelines from UK specialists, published yesterday.
The British Society for Allergy & Clinical Immunology says it has updated guidance from ten years ago on treating both allergic and non-allergic rhinitis.
It says most patients will need a regular topical nasal corticosteroid spray – although non-sedating histamines may help mild cases.
When this is insufficient, combination therapy involving intranasal corticosteroid and intranasal antihistamine is most effective, the guidance says.
The guidance goes on to set out how to test for allergens responsible for allergic rhinitis.
Society president Dr Shuaib Nasser said: "All rhinitis is not allergic and an understanding of the underlying mechanism, co-morbidities and specific triggers improves the accuracy of diagnosis and aids management."
Clinical & Experimental Allergy 10 July 2017; doi: 10.1111/cea.12953. [abstract]
Leave a Reply